Cargando…

Biased agonism

Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a lar...

Descripción completa

Detalles Bibliográficos
Autor principal: Kenakin, Terry
Formato: Texto
Lenguaje:English
Publicado: Biology Reports Ltd 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948287/
https://www.ncbi.nlm.nih.gov/pubmed/20948603
http://dx.doi.org/10.3410/B1-87
_version_ 1782187438334017536
author Kenakin, Terry
author_facet Kenakin, Terry
author_sort Kenakin, Terry
collection PubMed
description Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a large body of data that suggest that some agonists produce activation of some but not all available pathways. These agonists are referred to as ‘biased’ in that they select which signaling pathways become activated upon binding to the receptor. The data to support this mechanism as well as ideas on the possible therapeutic application of this effect will be discussed.
format Text
id pubmed-2948287
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Biology Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29482872010-10-14 Biased agonism Kenakin, Terry F1000 Biol Rep Review Article Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a large body of data that suggest that some agonists produce activation of some but not all available pathways. These agonists are referred to as ‘biased’ in that they select which signaling pathways become activated upon binding to the receptor. The data to support this mechanism as well as ideas on the possible therapeutic application of this effect will be discussed. Biology Reports Ltd 2009-11-26 /pmc/articles/PMC2948287/ /pubmed/20948603 http://dx.doi.org/10.3410/B1-87 Text en © 2009 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Kenakin, Terry
Biased agonism
title Biased agonism
title_full Biased agonism
title_fullStr Biased agonism
title_full_unstemmed Biased agonism
title_short Biased agonism
title_sort biased agonism
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948287/
https://www.ncbi.nlm.nih.gov/pubmed/20948603
http://dx.doi.org/10.3410/B1-87
work_keys_str_mv AT kenakinterry biasedagonism